Ketoconazole treatment of type 1 autoimmune polyglandular syndrome: effects on pituitary-adrenal axis

J Pediatr. 1986 Aug;109(2):363-6. doi: 10.1016/s0022-3476(86)80406-1.

Authors

P Feuillan, M Poth, W Reilly, G Bright, D L Loriaux, G P Chrousos

PMID: 3016223
DOI: 10.1016/s0022-3476(86)80406-1

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adrenocorticotropic Hormone
Autoimmune Diseases / drug therapy*
Autoimmune Diseases / genetics
Autoimmune Diseases / physiopathology
Candidiasis, Oral / drug therapy
Candidiasis, Oral / etiology
Child
Corticotropin-Releasing Hormone
Endocrine System Diseases / drug therapy*
Endocrine System Diseases / genetics
Endocrine System Diseases / physiopathology
Female
Genes, Recessive
Humans
Ketoconazole / adverse effects
Ketoconazole / therapeutic use*
Male
Pituitary-Adrenal Function Tests
Pituitary-Adrenal System / drug effects*
Pituitary-Adrenal System / physiopathology

Substances

Adrenocorticotropic Hormone
Corticotropin-Releasing Hormone
Ketoconazole